Skip to main content

Military Health System

Telemedicine Privilege by Proxy Expands Access to MHS Care

Image of Infographic featuring Lt Col Legault. The MHS’s Telemedicine Privilege by Proxy is a force multiplier that saves time, improves processes, and removes barriers to care for those we serve.

Recommended Content:

Coronavirus & the MHS Response | Telehealth Program

Part of putting patients at the center of everything we do is ensuring patients can quickly access high-quality care – particularly specialty care – wherever they happen to be.

Virtual health is central to increasing timely access to care, which is why the MHS has Telemedicine Privilege by Proxy. This fast, efficient process that enables providers to file one application and get permission to virtually treat patients anywhere in the Military Health System.

Telemedicine Privilege by Proxy plays a crucial role in meeting one of the MHS's biggest clinical needs: expanding access to limited specialty-care resources across the enterprise, especially to small, remote locations.

The single, centralized process has also made it up to 30 times faster for providers to get permission to deliver care virtually at military hospitals and clinics. It only takes three to five days, down from 90 days or more.

The MHS's Telemedicine Privilege by Proxy is a force multiplier that saves time, improves processes, and removes barriers to care for those we serve.

By facilitating virtual health across state and federal jurisdictions, the process is an invaluable tool to increase military readiness, improve access, improve outcomes, and lower costs.

Telemedicine Privilege by Proxy offers providers opportunities to improve all care, both virtual and in person. The process enables providers to deliver virtual care when appropriate and focus more effectively on patients that need in-person treatment.

It also enables providers to share their expertise outside their home facilities to help patients around the world.

Easing the Burden

The MHS Virtual Medical Center coordinates Telemedicine Privilege by Proxy as part of helping execute virtual health care across the MHS.

The process decreases administrative burdens on military hospitals and clinics by handling two key tasks:

  1. It confirms provider's credentials and privileges at their primary facilities.
  2. It then facilitates providers getting the same privileges for virtual care at other facilities, enabling quick access to patients at different locations as needed.

COVID-19 Impact

The COVID-19 pandemic forced the MHS to rapidly expand the reach and capabilities of its virtual health offerings to ensure continuity of care while keeping providers and patients safe.

Now that virtual health has become a permanent, growing part of MHS care delivery, many providers – and their patients – want to continue using virtual care.

Telemedicine Privilege by Proxy plays an essential role in meeting that demand. By expediting review and approval of providers to work virtually at other sites, the process enables providers and facilities to focus on delivering care more effectively – whether that care is in-person or virtual.

Telemedicine Privilege by Proxy will continue to help ensure service members, retirees, and their families get the care they deserve.

You also may be interested in...

Consolidated Department of Defense Coronavirus Disease 2019 Force Health Protection Guidance

Policy

Consolidates and updates the Department’s guidance regarding vaccination verification, vaccination status, COVID-19 testing, surveillance and screening testing, personnel protection on-site mask requirements, (e.g., DHA military medical treatment facilities, meetings, travel), and the protection of personally identifiable information.

DHA-IPM 20-004: Department of Defense (DOD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation

Policy

Establishes the Defense Health Agency’s procedures to implement instructions, assign responsibilities, and prescribe procedures for the DHA’s implementation of the DOD’s COVID-19 Vaccination Program.

Coronavirus Disease 2019 Vaccination Attestation, Screening Testing, and Vaccination Verification

Policy

This memorandum provides guidance on the implementation of vaccination, attestation, and testing requirements in accordance with the References listed in Attachment 1 to reduce the transmission of the virus that causes COVID-19.

Medical Logistics Guidance for the DoD Coronavirus Disease 2019 (COVID-19) Vaccination Program

Policy

Establishes the DHA's procedures for ordering, receiving, and managing COVID-19 Vaccines inventory and ancillary kits for enduring COVID-19 support.

TAB A MEO COVID19 Medical Coding Policy

Policy

Memorandum for DHA Staff - Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

DHA COVID19 Medical Coding PolicyV5 1v

Policy

Establishes the DHA procedures to standardize the coding for Coronavirus 2019 (COVID-19) within military medical treatment facilities (MTFs). This memorandum replaces DHA-Policy Memorandum 20-003 of July 1, 2020. Attachment 1 was updated to include the 2021 procedure and diagnosis codes for COVID-19, including the new vaccination and treatment codes.

Supplemental Guidance for Providing DOD Coronavirus Disease 2019 Vaccines to DOD Contractor Employees and Select Foreign Nationals

Policy

This memorandum provides supplemental guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines, in accordance with reference (a). The Defense Health Agency (DHA) is the lead coordinating DOD Component for executing this guidance, in coordination with the Military Departments and other DOD Components as appropriate.

HA Guidance for Coronavirus Disease 2019 (COVID-19) Laboratory Pre-Testing Questionnaire

Policy

This memorandum provides guidance for a COVID-19 laboratory pre-testing questionnaire that will be mandatory for all Active Duty Service members and encouraged for all other DOD beneficiaries treated at military medical treatment facilities.

Executive Order on Ensuring Access to United States Government COVID-19 Vaccines

Policy

This EO outlines who should receive priority access to COVID-19 vaccines developed in the United States or procured by the United States Government (“United States Government COVID-19 Vaccines”).

Coronavirus Disease 2019 Vaccine Guidance

Policy

This memorandum provides guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines. The Defense Health Agency (DHA) is the lead coordinating DOD Component for executing this guidance, in coordination with the Military Departments and other DOD Components.

Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

Policy

Establishes the DHA's plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic

Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

Policy

The Defense Health Agency (DHA) Memorandum, based on the authority of References (a) and (b), and in accordance with the guidance of References (c) and (d), establishes the DHA’s procedures to standardize the coding for Coronavirus 2019 (COVID-19) Military Medical Treatment Facilities (MTFs). This memorandum cancels and replaces DHA- Policy Memorandum 20-003 of (13 April 2020). A change was issued since the cancelled Memorandum 20-003 of (13 April 2020), the Attachment titles were updated to reflect that Attachments 1, 2, and 4 are considered Policies as opposed to Guidance.

Showing results 1 - 12 Page 1 of 1
Refine your search
Last Updated: August 10, 2022
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on Twitter Follow us on YouTube Sign up on GovDelivery